Back to Nuveen Asset Management, LLC Nuveen Asset Management, LLC

SMMTSMMT

Showing 2 of 12 quarters

Position history for Nuveen Asset Management, LLCNuveen Asset Management, LLC's holdings in Summit Therapeutics Inc.

As of its last 13F, for Q4 2024, Nuveen Asset Management held 234,426 shares of SMMT (Summit Therapeutics), worth $4.2M. It reduced the position by 35,329 shares (-13.1%) from Q3 2024. Nuveen Asset Management held SMMT from Q2 2023 to Q4 2024, across 7 quarterly 13F filings.

Current Value

$4.2M

Current Shares

234,426

Total Value Change

-$1.7M

Total Shares Change

-35,329

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Decreased
234,426
-13.1%
$4.2M0.0%$17.85
0
2024-Q3
Decreased
269,755
-2.5%
$5.9M0.0%$20.89
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used